Innoviva Company Profile (NASDAQ:INVA)

About Innoviva

Innoviva logoInnoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Its portfolio focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol (FF/VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). It operates in providing capital return to stockholders by maximizing the potential value of its respiratory assets partnered with GSK segment. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of VI, a LABA and FF, an inhaled corticosteroid (FF/VI) delivered via the ELLIPTA dry powder inhaler. ANORO ELLIPTA is a dual bronchodilator consisting of UMEC, a long-acting muscarinic antagonist (LAMA) and VI, a LABA for the treatment of chronic obstructive pulmonary diseases (COPD).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: INVA
  • CUSIP: 88338T10
Key Metrics:
  • Previous Close: $10.19
  • 50 Day Moving Average: $10.98
  • 200 Day Moving Average: $11.62
  • 52-Week Range: $7.56 - $14.15
  • Trailing P/E Ratio: 61.76
  • Foreward P/E Ratio: 8.86
  • P/E Growth: 0.24
  • Market Cap: $1.13B
  • Outstanding Shares: 111,202,000
  • Beta: 1.99
  • Net Margins: 20.15%
  • Return on Equity: -7.39%
  • Return on Assets: 6.31%
  • Debt-to-Equity Ratio: -1.99%
  • Current Ratio: 13.02%
  • Quick Ratio: 13.02%
Additional Links:
Companies Related to Innoviva:

Analyst Ratings

Consensus Ratings for Innoviva (NASDAQ:INVA) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $10.50 (3.04% upside)

Analysts' Ratings History for Innoviva (NASDAQ:INVA)
DateFirmActionRatingPrice TargetDetails
7/31/2016Robert W. BairdReiterated RatingNeutral$9.00 -> $11.00View Rating Details
10/29/2015Cowen and CompanyLower Price TargetMarket Perform$15.00 -> $10.00View Rating Details
10/5/2015Morgan StanleyReiterated RatingOverweight$7.00 -> $9.00View Rating Details
9/10/2015Sanford C. BernsteinReiterated RatingMarket Perform$15.00View Rating Details
9/9/2015Bank of America Corp.DowngradeBuy -> Neutral$16.00 -> $13.00View Rating Details
12/2/2014Leerink SwannDowngradeOutperform -> Market Perform$17.00View Rating Details
(Data available from 10/21/2014 forward)


Earnings History for Innoviva (NASDAQ:INVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016Q316$0.19$38.71 millionN/AView Earnings Details
7/28/2016Q216$0.11$0.17$31.13 million$32.47 millionViewListenView Earnings Details
4/28/2016Q116$0.09$0.04$28.61 million$24.17 millionViewListenView Earnings Details
2/3/2016Q415$0.01$0.04$20.17 million$22.80 millionViewN/AView Earnings Details
10/28/2015Q315($0.03)($0.04)$15.23 million$13.56 millionViewListenView Earnings Details
7/29/2015Q2($0.06)($0.07)$10.90 million$10.70 millionViewListenView Earnings Details
5/6/2015Q115($0.08)($0.09)$6.80 millionViewListenView Earnings Details
2/18/2015Q414($0.15)($0.14)$5.42 million$7.30 millionViewN/AView Earnings Details
10/30/2014Q314($0.14)($0.19)$6.30 millionViewN/AView Earnings Details
8/18/2014($0.53)($0.18)ViewN/AView Earnings Details
8/6/2014Q214($0.44)($0.57)$4.39 million$0.93 millionViewN/AView Earnings Details
5/6/2014Q114($0.53)($0.62)$4.52 million$0.17 millionViewN/AView Earnings Details
2/6/2014Q413($0.38)($0.46)$6.03 million$1.60 millionViewN/AView Earnings Details
10/24/2013Q313$0.69($0.44)$3.08 million$0.44 millionViewN/AView Earnings Details
7/25/2013Q2 2013($0.46)($0.37)$1.43 million$1.33 millionViewN/AView Earnings Details
4/25/2013Q1 2013($0.38)($0.39)$2.71 million$1.34 millionViewN/AView Earnings Details
2/12/2013Q4 2012($0.36)($0.33)$3.88 million$5.80 millionViewN/AView Earnings Details
10/30/2012($0.39)($0.37)ViewN/AView Earnings Details
7/31/2012($0.42)($0.42)ViewN/AView Earnings Details
4/26/2012$1.02$0.93ViewN/AView Earnings Details
2/9/2012($0.38)($0.45)ViewN/AView Earnings Details
10/27/2011($0.33)($0.37)ViewN/AView Earnings Details
7/28/2011($0.27)($0.31)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Innoviva (NASDAQ:INVA)
Current Year EPS Consensus Estimate: $0.62 EPS
Next Year EPS Consensus Estimate: $1.15 EPS


Dividend History for Innoviva (NASDAQ:INVA)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Innoviva (NASDAQ:INVA)
Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 81.19%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2016Eric DesparbesCFOSell3,700$11.77$43,549.00View SEC Filing  
5/18/2016James L TyreeDirectorSell813$10.47$8,512.11View SEC Filing  
5/11/2015Plc GlaxosmithklineMajor ShareholderBuy85,579$1,369,260.00$117,179,901,540.00View SEC Filing  
8/13/2014Junning LeeVPSell53,424$22.50$1,202,040.00View SEC Filing  
8/12/2014Bradford J ShaferSVPSell28,156$22.13$623,092.28View SEC Filing  
8/11/2014Bradford J ShaferSVPSell27,108$22.12$599,628.96View SEC Filing  
9/12/2013Rick WinninghamCEOSell22,353$40.03$894,790.59View SEC Filing  
7/30/2013Mathai MammenSVPSell7,000$36.51$255,570.00View SEC Filing  
6/7/2013Bradford J ShaferSVPSell31,038$35.04$1,087,571.52View SEC Filing  
5/29/2013David L BrinkleyInsiderSell3,808$35.01$133,318.08View SEC Filing  
5/13/2013David L BrinkleyInsiderSell16,129$40.33$650,482.57View SEC Filing  
8/7/2012Michael W AguiarCFOSell60,000$27.04$1,622,400.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Innoviva (NASDAQ:INVA)
DateHeadline logoInnoviva to Report Third Quarter 2016 Financial Results on October 27 at 5:00 p.m. EDT (NASDAQ:INVA) - October 19 at 6:00 PM
News IconShares Worth Watching: Innoviva Inc (NYSE:INVA) - Recall News (NASDAQ:INVA) - October 19 at 10:36 AM logoLook Beyond Bargain Hunting: Buy 5 Stocks with Rising P/E (NASDAQ:INVA) - October 18 at 10:47 AM featured highlights: Hasbro, Asbury Automotive Group, Home Depot, Innoviva and ZIOPHARM Oncology (NASDAQ:INVA) - October 18 at 10:47 AM logoHow These Application Software Stocks are Faring? -- Paycom Software, Innoviva, Manhattan Associates, and Proofpoint (NASDAQ:INVA) - October 17 at 10:40 AM
News IconShare Value Diminishing Over Past Month: Innoviva, Inc. (NASDAQ:INVA) - CSZ News (NASDAQ:INVA) - October 15 at 5:21 PM
News IconActive Volume Stock: Innoviva, Inc. (NASDAQ:INVA) - FactsReporter (NASDAQ:INVA) - October 14 at 5:33 PM
News IconActive Volume Stock Update: Innoviva, Inc. (NASDAQ:INVA) - FactsReporter (NASDAQ:INVA) - October 12 at 5:40 PM logoTheravance Biopharma's Valuation Has Gotten A Little Carried Away (NASDAQ:INVA) - October 12 at 2:03 PM
News IconInnoviva, Inc. (NASDAQ:INVA) Upgrades/Downgrades review - Newburgh Press (NASDAQ:INVA) - October 10 at 10:19 AM logoSeth Klarman Made 3 Transactions in August (NASDAQ:INVA) - October 7 at 5:29 PM
News IconTarget Price Review & Stock Update on Innoviva Inc (NYSE:INVA) - Recall News (NASDAQ:INVA) - October 6 at 11:01 AM
News IconAnalysts Take the Wheel on Innoviva Inc (NYSE:INVA) Shares and Where They Might Be Headed - CSZ News (NASDAQ:INVA) - October 6 at 11:01 AM logoTop 5 Pharma stocks with strong earnings momentum. : October 5, 2016 (NASDAQ:INVA) - October 5 at 10:54 AM
News IconShares Slipping Lower Over the Past Month: Innoviva, Inc. (NASDAQ:INVA) - Post News (NASDAQ:INVA) - September 29 at 10:42 AM
News IconEarnings Analysis & Update for Innoviva Inc (NYSE:INVA)? - Frisco Fastball (NASDAQ:INVA) - September 16 at 5:29 PM
News IconShares Lower Over the Past Quarter: Innoviva, Inc. (NASDAQ:INVA) - Post News (NASDAQ:INVA) - September 11 at 9:54 AM logoInnoviva Inc. (INVA): Billionaire Seth Klarman's Baupost Group Reduces Stake - Insider Monkey (blog) (NASDAQ:INVA) - September 11 at 9:54 AM
News IconInnoviva Inc. (INVA): Billionaire Seth Klarman’s Baupost Group Reduces Stake (NASDAQ:INVA) - September 10 at 1:18 PM logoInnoviva (INVA), GlaxoSmithKline (GSK) Announce Publication of Positive Salford Lung Study Data - (NASDAQ:INVA) - September 8 at 5:31 PM
News IconStock Sliding Down Over the Last Month: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) - September 8 at 5:31 PM logoInnoviva to Present at Morgan Stanley Global Healthcare Conference and Rodman & Renshaw 19 th Annual Global Investment Conference (NASDAQ:INVA) - September 8 at 9:35 AM
News IconStock Trading Above Moving Averages: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) - September 7 at 5:49 PM
News IconInnoviva, Inc. (NASDAQ:INVA) To Report September 2016 Results - The Voice Registrar (NASDAQ:INVA) - September 7 at 5:49 PM logoInnoviva to Present at Morgan Stanley Global Healthcare Conference and Rodman & Renshaw 19th Annual Global Investment Conference (NASDAQ:INVA) - September 7 at 5:49 PM logoInnoviva (INVA), GlaxoSmithKline (GSK) Announce Publication of Positive Salford Lung Study Data (NASDAQ:INVA) - September 6 at 5:38 PM logoINNOVIVA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:INVA) - September 6 at 5:38 PM logoInnoviva to Present at Wells Fargo and Baird Healthcare Conferences in Early September (NASDAQ:INVA) - August 31 at 10:26 AM logoProofpoint : Application Software Stocks Under Scanner -- Rubicon Project, Mitek Systems, Innoviva, and Proofpoint (NASDAQ:INVA) - August 29 at 10:12 AM logoINVA Crosses Above Average Analyst Target (NASDAQ:INVA) - August 29 at 10:12 AM logoInnoviva Breaks Below 200-Day Moving Average - Notable for INVA - Nasdaq (NASDAQ:INVA) - August 25 at 5:41 PM logoInnoviva Breaks Below 200-Day Moving Average - Notable for INVA (NASDAQ:INVA) - August 25 at 10:41 AM logoInnoviva Becomes Oversold (INVA) (NASDAQ:INVA) - August 24 at 5:33 PM
News IconStock Gaining Over the Past Six Months: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) - August 22 at 10:14 AM
News IconShares Holding Above Moving Averages: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) - August 19 at 5:40 PM
News IconInstitutions Have Decreased Their Ownership of Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) - August 19 at 8:38 AM logo3 Pullback Plays For A Quiet Summer Market (JCP, ADXS) (NASDAQ:INVA) - August 18 at 5:41 PM logoINNOVIVA, INC. Financials (NASDAQ:INVA) - August 12 at 5:45 PM logoOverboarded Directors at Valeant, Yahoo! and Elsewhere Struggle With Activists, M&A (NASDAQ:INVA) - August 12 at 5:45 PM logoETF’s with exposure to Innoviva, Inc. : August 5, 2016 (NASDAQ:INVA) - August 5 at 5:49 PM logoINNOVIVA, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:INVA) - August 5 at 8:41 AM logoInnoviva, Inc. :INVA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:INVA) - August 3 at 5:59 PM logoKeryx (KERX) Stock Down on Wider Q2 Loss, Supply Issues (NASDAQ:INVA) - August 2 at 10:29 AM logoInnoviva: Finally Starting To Gain Some Trust - Seeking Alpha (NASDAQ:INVA) - July 31 at 5:21 PM logoEdited Transcript of INVA earnings conference call or presentation 28-Jul-16 9:00pm GMT (NASDAQ:INVA) - July 29 at 4:20 PM logoInnoviva Reports Second Quarter 2016 Financial Results - Business Wire (press release) (NASDAQ:INVA) - July 29 at 8:37 AM logoInnoviva beats 2Q profit forecasts (NASDAQ:INVA) - July 28 at 6:34 PM logo4:17 pm Innoviva reports EPS in-line, beats on revs (NASDAQ:INVA) - July 28 at 4:17 PM logoINNOVIVA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:INVA) - July 28 at 4:14 PM logoInnoviva Reports Second Quarter 2016 Financial Results (NASDAQ:INVA) - July 28 at 4:05 PM


Innoviva (NASDAQ:INVA) Chart for Friday, October, 21, 2016

Last Updated on 10/21/2016 by Staff